The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBunzl Regulatory News (BNZL)

Share Price Information for Bunzl (BNZL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,106.00
Bid: 3,104.00
Ask: 3,108.00
Change: 0.00 (0.00%)
Spread: 4.00 (0.129%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3,106.00
BNZL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition

14 Sep 2021 07:00

RNS Number : 6131L
Bunzl PLC
14 September 2021
 

 

14 September 2021

 

BUNZL AGREES TO ACQUIRE US BASED SAFETY BUSINESS AND

HEALTHCARE DISTRIBUTOR IN AUSTRALASIA

 

Bunzl plc, the specialist international distribution and services Group, today announces that it has entered into agreements to acquire a US based safety business and a medical supplies distributor with operations in Australia and Singapore.

 

McCue Corporation ("McCue"), based in Boston, Massachusetts, is a leading business in the distribution of safety and asset protection solutions, and provides Bunzl with a strong position in this fast growing market segment. Supported by a strong portfolio of innovative own brand solutions and smart products, McCue specialises in the distribution of products such as safety barriers, floor railings and bumpers, for use in warehouses and high footfall environments spanning sectors such as grocery and ecommerce. The business has operations in Massachusetts, Texas and California, as well as in the UK and other international markets.

 

The business has delivered very strong double digit annual growth over the last three years. This trajectory continues, supported by the growth in ecommerce-based distribution activities, the importance of health and safety measures in operating environments and the increasing prevalence of higher value warehouse equipment which increases the importance of asset protection. In the 12 months to July 2021 McCue generated revenue of $90 million (c.£65 million), predominantly in the US. The business has an operating margin above the level typically experienced in the Group's safety businesses. The acquisition is subject to competition clearance in the US and is expected to complete later this year.

 

MedShop is an online distributor of medical supplies and devices to a diverse range of healthcare customers, predominately in Australia. The business has a strong digital platform and operations in Melbourne and in Singapore. MedShop generated revenue in 2020 of AUD 22 million (c.£12 million). The acquisition completed in early September.

 

Commenting on the acquisitions, Frank van Zanten, Chief Executive Officer of Bunzl, said:

 

"The acquisition of McCue represents an exciting expansion of our safety operations in North America and the UK. It is a high quality business with a strong leadership team and track record, with good opportunities for further growth supported by innovation and international expansion. It demonstrates the range of important value-added products and services the Group can provide to customers and our continual focus on evolving our portfolio alongside sector trends.

 

MedShop is a complementary business that builds on our capabilities in the Australian healthcare sector, allowing us to target an expanded customer base. The strength of the digitally focused leadership team supports the significant potential to grow the business in Australasia.

 

Year to date we have now agreed ten acquisitions, with a combined committed spend of approximately £390 million. Our balance sheet remains strong, providing opportunity to self-fund further acquisitions alongside an active pipeline and ongoing discussions."

 

 

Enquiries:

 

Bunzl plc

Frank van Zanten, Chief Executive Officer

Richard Howes, Chief Financial Officer

Tel: +44 (0)20 7725 5000

Tulchan

Martin Robinson

Suniti Chauhan

Tel: +44 (0)20 7353 4200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQLJMATMTBBBTB
Date   Source Headline
2nd May 20242:00 pmRNSDirector/PDMR Shareholding
2nd May 20248:00 amRNSAdditional Listing
1st May 20245:00 pmRNSDirector/PDMR Shareholding
1st May 202410:00 amRNSBlock listing Interim Review
1st May 20249:18 amRNSTotal Voting Rights
25th Apr 20244:45 pmRNSDirector/PDMR Shareholding
24th Apr 20242:51 pmRNSResult of AGM
24th Apr 20247:00 amRNSTrading Statement
22nd Apr 20244:36 pmRNSDirector/PDMR Shareholding
18th Apr 20248:00 amRNSAdditional Listing
11th Apr 20248:00 amRNSAdditional Listing
3rd Apr 20245:28 pmRNSDirector/PDMR Shareholding
3rd Apr 20249:09 amRNSDirector/PDMR Shareholding
2nd Apr 20241:50 pmRNSTotal Voting Rights
21st Mar 20248:00 amRNSAdditional Listing
15th Mar 20243:28 pmRNSAnnual Financial Report
7th Mar 20248:00 amRNSAdditional Listing
5th Mar 20245:05 pmRNSDirector/PDMR Shareholding
4th Mar 20243:03 pmRNSDirector/PDMR Shareholding
1st Mar 202411:35 amRNSTotal Voting Rights
28th Feb 20243:17 pmRNSDirector/PDMR Shareholding
27th Feb 20245:26 pmRNSDirector/PDMR Shareholding
26th Feb 202410:30 amRNSDividend Declaration
26th Feb 20247:00 amRNSFinal Results
26th Feb 20247:00 amRNSAcquisition
5th Feb 20242:20 pmRNSDirector/PDMR Shareholding
1st Feb 20245:08 pmRNSTotal Voting Rights
12th Jan 20244:54 pmRNSDirector/PDMR Shareholding
11th Jan 20243:50 pmRNSDirector/PDMR Shareholding
2nd Jan 202410:57 amRNSTotal Voting Rights
15th Dec 20235:10 pmRNSHolding(s) in Company
14th Dec 20237:00 amRNSTrading Statement
8th Dec 20235:32 pmRNSDirector/PDMR Shareholding
1st Dec 202311:32 amRNSTotal Voting Rights
20th Nov 20236:30 pmRNSPublication of Admission Particulars
3rd Nov 20239:30 amRNSDirector Declaration
2nd Nov 20232:29 pmRNSDirector/PDMR Shareholding
1st Nov 202311:24 amRNSTotal Voting Rights
1st Nov 20239:00 amRNSBlock listing Interim Review
24th Oct 20237:00 amRNSTrading Statement
6th Oct 20235:08 pmRNSDirector/PDMR Shareholding
4th Oct 20231:40 pmRNSDirector/PDMR Shareholding
2nd Oct 20231:34 pmRNSTotal Voting Rights
2nd Oct 20231:33 pmRNSDirector/PDMR Shareholding
26th Sep 20232:10 pmRNSDirector/PDMR Shareholding
1st Sep 20232:30 pmRNSTotal Voting Rights
31st Aug 202310:30 amRNSDirector/PDMR Shareholding
29th Aug 202310:00 amRNSDividend Declaration
29th Aug 20237:00 amRNSHalf-year Report
29th Aug 20237:00 amRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.